Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07419854 · ClinicalTrials.gov registry record · Phase 4
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
A Phase 4 study of Volume Loss (Soft Tissue Ptosis or Atrophy ), sponsored by Kalpna Kay Durairaj, MD, FACS.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT07419854 is a Phase 4 study of Volume Loss (Soft Tissue Ptosis or Atrophy ) that is actively recruiting participants, run by Kalpna Kay Durairaj, MD, FACS. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07419854, a Phase 4 study of Volume Loss (Soft Tissue Ptosis or Atrophy ), is actively recruiting participants, sponsored by Kalpna Kay Durairaj, MD, FACS.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the potential of Calcium Hydroxylapatite (CaHA) to restore facial volume and improve skin quality in patients with GLP-1 receptor agonist-associated facial volume loss. Participants will: * Schedule first dose of a prescribed GLP-1 receptor agonist drug to coincide with the baseline visit of this study * Be randomly assigned to one of two groups (Group A will receive off-label injections of hyperdiluted CaHA at Month 0. Group B will receive on-label injections of CaHA after serving as a control group through Month 6) * Have clinical photos taken at each office visit to track progress
Conditions Studied
Interventions
- DEVICE Hyperdiluted Calcium Hydroxylapatite
- DEVICE Calcium hydroxylapatite
- DEVICE Calcium hydroxylapatite with integral lidocaine
Study Locations (1)
California
- K. Kay Durairaj, MD, A Medical Corp. - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07419854
The ClinicalTrials.gov registry entry for NCT07419854 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kalpna Kay Durairaj, MD, FACS, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Volume Loss (Soft Tissue Ptosis or Atrophy ) appearing as the primary indexed condition, and to 3 interventions - of which Hyperdiluted Calcium Hydroxylapatite is the first listed.
NCT07419854 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07419854 about?
NCT07419854 is a clinical study titled "Restoring Facial Volume After GLP-1 Weight Loss With Radiesse". The goal of this clinical trial is to evaluate the potential of Calcium Hydroxylapatite (CaHA) to restore facial volume and improve skin quality in patients with GLP-1 receptor agonist-associated facial volume loss. Participants will: * Schedule first dose of a prescribed GLP-1 receptor agonist dru...
What is the current status of trial NCT07419854?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2026-02. Estimated completion is 2027-09.
What conditions does trial NCT07419854 study?
This clinical trial studies the following conditions: Volume Loss (Soft Tissue Ptosis or Atrophy ).
What interventions are being tested in trial NCT07419854?
The interventions under investigation include: Hyperdiluted Calcium Hydroxylapatite (DEVICE), Calcium hydroxylapatite (DEVICE), Calcium hydroxylapatite with integral lidocaine (DEVICE).
Who is sponsoring clinical trial NCT07419854?
This trial is sponsored by Kalpna Kay Durairaj, MD, FACS, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07419854 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.